Addex Therapeutics Ltd (ADXN)
9.15
+0.20
(+2.23%)
USD |
NASDAQ |
May 06, 16:00
Addex Therapeutics Free Cash Flow (Quarterly): -0.5575M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.5575M |
| September 30, 2023 | -2.652M |
| June 30, 2023 | -3.148M |
| March 31, 2023 | -2.550M |
| December 31, 2022 | -3.396M |
| September 30, 2022 | -2.778M |
| June 30, 2022 | -5.816M |
| March 31, 2022 | -5.245M |
| December 31, 2021 | -3.306M |
| September 30, 2021 | -2.687M |
| Date | Value |
|---|---|
| June 30, 2021 | -7.066M |
| March 31, 2021 | -3.065M |
| December 31, 2020 | 0.9689M |
| September 30, 2020 | -3.297M |
| June 30, 2020 | -6.418M |
| March 31, 2020 | -4.308M |
| December 31, 2019 | 0.0999M |
| September 30, 2019 | -5.048M |
| June 30, 2019 | -2.049M |
| March 31, 2019 | -2.576M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.066M
Minimum
Jun 2021
0.9689M
Maximum
Dec 2020
-3.28M
Average
-3.148M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| AC Immune SA | -17.38M |
| CRISPR Therapeutics AG | -96.81M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -17.34M |
| MoonLake Immunotherapeutics | -12.34M |